Evaluation of the Videodrama Therapeutic Device for Children With Autism Spectrum Disorders

NCT06443320 · tracked via the Priya Life Science France tracker

Sponsor

Centre Hospitalier Intercommunal Robert Ballanger

Phase

Not applicable

Started

2023-12-04

Last updated

2025-02-06

Condition(s) studied

Autism Spectrum Disorder (ASD)

Investigational drug(s) / intervention(s)

patient included in experimental groupe will view the video excerpt, a playtime, a drawing activities

patient included in experimental groupe will view the video excerpt, a playtime, a drawing activities: Patients included in the videodrama arm will participate in a total of 18 videodrama sessions, with one session per week. Each session will include a patient welcome period, the viewing of a video excerpt (in slow motion or not), a playtime, a drawing period, and a group closing session. For the play and drawing activities, the same materials will be provided in each department and for each group, including small figurines, animals, shapes (such as cubes, triangles, circles), small plush toys, markers, colored pencils, and A4 white sheets of paper.

Study summary

Autism spectrum disorder (ASD) is a neurodevelopmental disorder (Valerie, Sperenza, 2009) that begins early in development, characterized by persistent deficits in communication and social interactions across various contexts and restricted, repetitive patterns of behavior, interests, or activities. These symptoms significantly impact social, school/professional functioning, or other important areas and are not better explained by intellectual disability or global developmental delay (American Psychiatric Association, 2013).

Eligibility

Sex

ALL

Min age

3 Years

Max age

15 Years

Healthy volunteers

Inclusion Criteria: * Children aged 3 to 15 years. * Clinically confirmed ASD by a psychiatrist. * Parental or legal guardian consent for participation. * Child showing a strong interest in screens and/or video content. * Ability to tolerate the presence of other children. * Minimum of 18 video drama sessions. * Not having benefited from disease care in the past. * Affiliation to a social security system Exclusion Criteria: * No ASD diagnosis. * Younger than 3 or older than 15 at the study start. * No interest in screens or video content. * Parental or legal guardian refusal for participation. * Dropping out before completing 18 sessions. * Patient having benefited a disease care in the past

Primary outcome measure(s)

Dunn Sensory Profile questionnaire — 9 months
Sensory atypicality frequency will be assessed using the Dunn Sensory Profile questionnaire, describing child behavior in various sensory experiences

Trial sites (1)

Facility	City	Region	Status
CHI Robert Ballanger	Aulnay-sous-Bois	France	Recruiting

More Centre Hospitalier Intercommunal Robert Ballanger trials in France

Evaluation of A-DIVA Score Effectiveness at Admission for Preserving Venous Capital in Patients With Difficult Access Starting soon

Coercive Control and Intimate Partner Violence Starting soon

Other trials for the same condition

Neuromotor Task Training in Autistic Children With Motor Difficulties Starting soon

Characterization of the Natural History of Microduplication Syndrome 7q11.23 Recruiting

Prospective Study to Determine the Prevalence of Signs of Central Sensitization in Adults With ASD Without Intellectual Developmental Disorders Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06443320 on ClinicalTrials.gov ↗ ← All trials in France